DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,258 filers reported holding DANAHER CORPORATION in Q3 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $286,573 | -4.4% | 1,147 | -4.5% | 0.15% | -3.9% |
Q1 2024 | $299,908 | +10.5% | 1,201 | +2.4% | 0.15% | +10.1% |
Q4 2023 | $271,356 | -10.9% | 1,173 | -4.4% | 0.14% | -22.5% |
Q3 2023 | $304,414 | +18.3% | 1,227 | +14.5% | 0.18% | +7.9% |
Q2 2023 | $257,280 | -5.3% | 1,072 | -0.6% | 0.16% | -2.4% |
Q1 2023 | $271,694 | -10.6% | 1,078 | -5.9% | 0.17% | -9.1% |
Q4 2022 | $303,889 | -12.4% | 1,145 | -14.9% | 0.19% | -20.2% |
Q3 2022 | $347,000 | +2.4% | 1,345 | +0.4% | 0.23% | +4.5% |
Q2 2022 | $339,000 | -13.7% | 1,339 | 0.0% | 0.22% | -6.3% |
Q1 2022 | $393,000 | -19.1% | 1,339 | -9.5% | 0.24% | -19.9% |
Q4 2021 | $486,000 | +8.0% | 1,479 | 0.0% | 0.30% | -0.7% |
Q3 2021 | $450,000 | +13.4% | 1,479 | 0.0% | 0.30% | +13.3% |
Q2 2021 | $397,000 | +19.6% | 1,479 | 0.0% | 0.26% | +14.8% |
Q1 2021 | $332,000 | +0.6% | 1,479 | -0.3% | 0.23% | -5.3% |
Q4 2020 | $330,000 | +7.8% | 1,484 | +4.4% | 0.24% | -6.2% |
Q3 2020 | $306,000 | +18.6% | 1,422 | -2.7% | 0.26% | +17.7% |
Q2 2020 | $258,000 | +24.6% | 1,462 | -2.4% | 0.22% | +15.8% |
Q1 2020 | $207,000 | -11.9% | 1,498 | -2.3% | 0.19% | +11.1% |
Q4 2019 | $235,000 | +6.3% | 1,534 | 0.0% | 0.17% | -0.6% |
Q3 2019 | $221,000 | +0.5% | 1,534 | 0.0% | 0.17% | -3.4% |
Q2 2019 | $220,000 | +7.3% | 1,534 | -1.5% | 0.18% | +16.3% |
Q1 2019 | $205,000 | +18.5% | 1,557 | -7.4% | 0.15% | +10.1% |
Q4 2018 | $173,000 | -2.3% | 1,682 | +3.3% | 0.14% | +19.8% |
Q3 2018 | $177,000 | +9.3% | 1,629 | -0.7% | 0.12% | +2.7% |
Q2 2018 | $162,000 | -12.0% | 1,640 | -12.8% | 0.11% | -14.4% |
Q1 2018 | $184,000 | -9.4% | 1,880 | -14.2% | 0.13% | +0.8% |
Q4 2017 | $203,000 | -5.1% | 2,191 | -12.4% | 0.13% | -6.4% |
Q3 2017 | $214,000 | -7.0% | 2,501 | -8.1% | 0.14% | -4.1% |
Q2 2017 | $230,000 | -0.4% | 2,720 | +0.8% | 0.15% | -0.7% |
Q1 2017 | $231,000 | -7.6% | 2,699 | -16.1% | 0.15% | -1.3% |
Q4 2016 | $250,000 | -16.9% | 3,218 | -16.4% | 0.15% | -16.3% |
Q3 2016 | $301,000 | -46.0% | 3,851 | -30.2% | 0.18% | -44.9% |
Q2 2016 | $557,000 | -60.4% | 5,515 | -62.8% | 0.32% | -56.0% |
Q1 2016 | $1,408,000 | +5.9% | 14,840 | +3.6% | 0.73% | +4.3% |
Q4 2015 | $1,330,000 | +8.3% | 14,325 | -0.6% | 0.70% | +2.0% |
Q3 2015 | $1,228,000 | +1.7% | 14,414 | +2.1% | 0.69% | +12.7% |
Q2 2015 | $1,208,000 | +1.7% | 14,114 | +0.9% | 0.61% | +2.2% |
Q1 2015 | $1,188,000 | -1.9% | 13,994 | -0.9% | 0.60% | -0.8% |
Q4 2014 | $1,211,000 | +5.6% | 14,127 | -6.5% | 0.60% | +6.2% |
Q3 2014 | $1,147,000 | -3.5% | 15,102 | 0.0% | 0.57% | -0.5% |
Q2 2014 | $1,189,000 | +5.8% | 15,102 | +0.7% | 0.57% | +5.9% |
Q1 2014 | $1,124,000 | +2.7% | 14,992 | +5.7% | 0.54% | +5.5% |
Q4 2013 | $1,094,000 | +5.0% | 14,177 | -5.7% | 0.51% | -0.2% |
Q3 2013 | $1,042,000 | +8.7% | 15,027 | -0.8% | 0.51% | +8.0% |
Q2 2013 | $959,000 | – | 15,152 | – | 0.48% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |